Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CONMED Corp Director's Dealing 2021

May 6, 2021

31971_dirs_2021-05-06_3f5adcb3-5a8f-4dfb-b00d-08bd24b43355.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CONMED Corp (CNMD)
CIK: 0000816956
Period of Report: 2021-05-05

Reporting Person: Cohen Heather L (EVP CORP HR)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2021-05-05 Common Stock S 4017 $141.673 Disposed 25056 Direct
2021-05-05 Common Stock S 450 $143.327 Disposed 24606 Direct
2021-05-05 Common Stock S 150 $144.15 Disposed 24456 Direct

Footnotes

F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $141.30 to $142.14. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.

F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $142.82 to $143.76. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.

F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $143.83 to $144.79. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.